|Announcement Title||Change - Announcement of Cessation|
|Date & Time of Broadcast||Mar 8, 2023 22:00|
|Announcement Sub Title||CESSATION OF CHIEF OPERATING OFFICER|
|Submitted By (Co./ Ind. Name)||Mr Yet Kum Meng|
|Designation||Chief Executive Officer and Executive Director|
|Description (Please provide a detailed description of the event in the box below)||Cessation of Chief Operating Officer.
This announcement has been reviewed by the Company's sponsor, PrimePartners Corporate Finance Pte. Ltd. (the "Sponsor"). It has not been examined or approved by the Singapore Exchange Securities Trading Limited (the "Exchange") and the Exchange assumes no responsibility for the contents of this document, including the correctness of any of the statements or opinions made or reports contained in this document.
The contact person for the Sponsor is Ms. Foo Jien Jieng, 16 Collyer Quay, #10-00 Collyer Quay Centre, Singapore 049318, firstname.lastname@example.org.
|Name Of Person||Joelle Lee Siew Hong|
|Is effective date of cessation known?||Yes|
|If yes, please provide the date||05/06/2023|
|Detailed Reason (s) for cessation||Ms. Joelle Lee Siew Hong ("Ms. Joelle") had, on 6 March 2023, tendered her resignation as Chief Operating Officer of OUE Lippo Healthcare Limited (the "Company" and together with its subsidiaries, the "Group"), due to personal interests. Ms. Joelle's last day of service with the Company will be 5 June 2023. Upon Ms. Joelle's last day of service, she will be engaged as a Consultant for a period of 3 months from 6 June 2023 to 5 September 2023 to ensure a smooth transition of the Group's overall operations.
In addition, the Company confirms that there are no concerns with regards to the overall operations of the Group that led to the cessation of Ms. Joelle as the Chief Operating Officer and there are no disagreements between Ms. Joelle and the Board of Directors (the "Board") of the Company with regards to practices that would have an impact to the Group's overall operations.
After having interviewed Ms. Joelle and to the best of its knowledge, the Company's Sponsor, PrimePartners Corporate Finance Pte. Ltd., is satisfied that save as disclosed in this announcement, there are no other material reasons for the cessation of Ms. Joelle as the Chief Operating Officer of the Company.
The Company is in the process of finding a suitable replacement and will make the necessary announcement when a suitable candidate is appointed.
The Board would like to extend its gratitude and appreciation to Ms. Joelle for her invaluable contributions to the Company during her tenure of service.
|Are there any unresolved differences in opinion on material matters between the person and the board of directors, including matters which would have a material impact on the group or its financial reporting?||No|
|Is there any matter in relation to the cessation that needs to be brought to the attention of the shareholders of the listed issuer?||No|
|Any other relevant information to be provided to shareholders of the listed issuer?||No|
|Date of Appointment to current position||03/01/2022|
|Does the AC have a minimum of 3 members (taking into account this cessation)?||Yes|
|Number of Independent Directors currently resident in Singapore (taking into account this cessation)||3|
|Number of cessations of appointments specified in Listing Rule 704 (7) or Catalist Rule 704 (6) over the past 12 months||1|
|Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)||Chief Operating Officer|
|Role and responsibilities||Responsible for the Group's overall operations.|
|Familial relationship with any director and/ or substantial shareholder of the listed issuer or of any of its principal subsidiaries||Nil|
|Shareholding interest in the listed issuer and its subsidiaries?||No|
|Past (for the last 5 years)||Refer to Appendix A|
|Present||Refer to Appendix B|